In the United States, a federal class-action lawsuit was filed last month alleging that people incarcerated in Department of Corrections facilities in the state of Nevada do not have adequate access to direct-acting antivirals (DAAs), the standard of care for the treatment and cure of chronic hepatitis C. According to an article in the Las…
Tag: harm reduction
Research: Needle/syringe programs highly cost-effective for hep C prevention in UK
According to research published in Addiction, needle and syringe programs are a highly cost-effective means of preventing hepatitis C transmission among people who inject drugs. Investment in such programming, the results show, could save millions of pounds in treatment costs in the United Kingdom (UK). Using data from three UK cities, the researchers estimated the…
News: Europe’s hepatitis challenge
An article published in the Bulletin of the World Health Organization (WHO) this month looks at the factors slowing progress in preventing and treating hepatitis B and C infections in Europe. Experts consulted highlight vaccination, voluntary testing, policy development, a focus on high-risk groups like intravenous drug users, standardized data collection, and service integration as…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 